220 related articles for article (PubMed ID: 34013451)
1. Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial.
Delrieu L; Martin A; Touillaud M; Pérol O; Morelle M; Febvey-Combes O; Freyssenet D; Friedenreich C; Dufresne A; Bachelot T; Heudel PE; Trédan O; Crochet H; Bouhamama A; Pilleul F; Pialoux V; Fervers B
Breast Cancer Res Treat; 2021 Aug; 188(3):601-613. PubMed ID: 34013451
[TBL] [Abstract][Full Text] [Related]
2. Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?
Deluche E; Lachatre D; Di Palma M; Simon H; Tissot V; Vansteene D; Meingan P; Mohebi A; Lenczner G; Pigneur F; Goldwasser F; Raynard B;
Breast; 2022 Feb; 61():84-90. PubMed ID: 34923226
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity.
Bellanti F; Romano AD; Lo Buglio A; Castriotta V; Guglielmi G; Greco A; Serviddio G; Vendemiale G
Maturitas; 2018 Mar; 109():6-12. PubMed ID: 29452783
[TBL] [Abstract][Full Text] [Related]
4. Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer.
Delrieu L; Touillaud M; Pérol O; Morelle M; Martin A; Friedenreich CM; Mury P; Dufresne A; Bachelot T; Heudel PE; Fervers B; Trédan O; Pialoux V
Oxid Med Cell Longev; 2021; 2021():6694594. PubMed ID: 34326920
[TBL] [Abstract][Full Text] [Related]
5. 7β-Hydroxycholesterol and 7-ketocholesterol: New oxidative stress biomarkers of sarcopenia inducing cytotoxic effects on myoblasts and myotubes.
Ghzaiel I; Zarrouk A; Pires V; de Barros JP; Hammami S; Ksila M; Hammami M; Ghrairi T; Jouanny P; Vejux A; Lizard G
J Steroid Biochem Mol Biol; 2023 Sep; 232():106345. PubMed ID: 37286110
[TBL] [Abstract][Full Text] [Related]
6. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
Aleixo GFP; Williams GR; Nyrop KA; Muss HB; Shachar SS
Breast Cancer Res Treat; 2019 Oct; 177(3):569-579. PubMed ID: 31292800
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
[TBL] [Abstract][Full Text] [Related]
8. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
[TBL] [Abstract][Full Text] [Related]
9. Elevated hydrogen peroxide and decreased catalase and glutathione peroxidase protection are associated with aging sarcopenia.
Sullivan-Gunn MJ; Lewandowski PA
BMC Geriatr; 2013 Oct; 13():104. PubMed ID: 24093947
[TBL] [Abstract][Full Text] [Related]
10. Comment on: sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer-results from the ABLE feasibility trial.
Kirac Utku I; Safer U
Breast Cancer Res Treat; 2022 Apr; 192(2):463. PubMed ID: 34994878
[No Abstract] [Full Text] [Related]
11. Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer.
Sheean P; Gomez-Perez S; Joyce C; O'Connor P; Bojko M; Smith A; Vasilopoulos V; Rao R; Sclamberg J; Robinson P
Breast Cancer Res Treat; 2021 Nov; 190(1):121-132. PubMed ID: 34389926
[TBL] [Abstract][Full Text] [Related]
12. Serum markers of inflammation and oxidative stress in sarcopenia.
Can B; Kara O; Kizilarslanoglu MC; Arik G; Aycicek GS; Sumer F; Civelek R; Demirtas C; Ulger Z
Aging Clin Exp Res; 2017 Aug; 29(4):745-752. PubMed ID: 27571781
[TBL] [Abstract][Full Text] [Related]
13. A moderate intensity exercise program improves physical function and oxidative damage in older women with and without sarcopenic obesity.
Gutiérrez-López L; Olivares-Corichi IM; Martínez-Arellanes LY; Mejía-Muñoz E; Polanco-Fierro JA; García-Sánchez JR
Exp Gerontol; 2021 Jul; 150():111360. PubMed ID: 33878422
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapy.
Ueno A; Yamaguchi K; Sudo M; Imai S
Support Care Cancer; 2020 Sep; 28(9):4249-4254. PubMed ID: 31900607
[TBL] [Abstract][Full Text] [Related]
15. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of sarcopenia in very old patients with hip fracture.
Sánchez-Castellano C; Martín-Aragón S; Bermejo-Bescós P; Vaquero-Pinto N; Miret-Corchado C; Merello de Miguel A; Cruz-Jentoft AJ
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):478-486. PubMed ID: 31912666
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia and Skeletal Muscle Quality as Predictors of Postoperative Complication and Early Mortality in Gynecologic Cancer.
Silva de Paula N; de Aguiar Bruno K; Azevedo Aredes M; Villaça Chaves G
Int J Gynecol Cancer; 2018 Feb; 28(2):412-420. PubMed ID: 29266018
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Oxidative Stress Parameters and Antioxidant Status in Plasma and Erythrocytes of Elderly Diabetic Patients with Sarcopenia.
Küçükdiler AHE; Varlı M; Yavuz Ö; Yalçın A; Selvi Öztorun H; Devrim E; Aras S
J Nutr Health Aging; 2019; 23(3):239-245. PubMed ID: 30820511
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
Prado CM; Baracos VE; McCargar LJ; Reiman T; Mourtzakis M; Tonkin K; Mackey JR; Koski S; Pituskin E; Sawyer MB
Clin Cancer Res; 2009 Apr; 15(8):2920-6. PubMed ID: 19351764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]